David Walk

,

Credentials

MD, FAAN

Bio

My clinical and research interests include motor neuron disorders, Charcot-Marie-Tooth (CMT), and other neuropathies

Research Summary

 

Research Funding Grants:
2021-present PharNEXT
PXT3006
Local Principal Investigator

2020-present ALS Platform Trial
Healy Center for ALS
Local Principal Investigator

2021-present MediciNova
COMBAT-ALS
Co-Investigator

2021-presen Apellis
APL-ALS-206
Co-Investigator

2021-present PHARNext
Phase III Trial of PXT3006 in CMT1A
Local Principal Investigator

2021-present Spastic Paraplegia Foundation
PLS Natural History Study
Local Principal Investigator

2016-present NIH Advancing Treatment for Pancreatitis: A Prospective Observational Study of TPIAT Co-Investigator

2016-present PHARNext
Phase III Trial of PXT3003 in CMT1A and Open-Label Extension
Local Principal Investigator

2016-present Inherited Neuropathy Consortium Rare Disease Clinical Research Network Genetics of CMT - Modifiers of CMT1A, New Causes of CMT
Local Principal Investigator

2016-present Inherited Neuropathy Consortium Rare Disease Clinical Research Network A Natural History Study of CMT1B, CMT2A, CMT4A and CMT4C
Local Principal Investigator

 

Clinical Summary

Clinical Interests: ALS and other motor neuron disorders; Charcot-Marie-Tooth (CMT); Neuropathy

My career focus has been on the diagnosis and management of neuropathy, including small fiber neuropathy, inflammatory neuropathy, and inherited neuropathy, as well as ALS and other motor neuron disorders. Our clinics emphasize multidisciplinary management, utilizing interdisciplinary teams of content and disease-state experts.